EntyvioConnect Co-Pay Assistance Program
Takeda Pharmaceuticals U.S.A., Inc. · Entyvio
Patient pays: as little as $0 per dose (IV or Pen)
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Entyvio assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Entyvio help that still works on Medicare or Medicaid - the programs copay cards leave out.
Entyvio (vedolizumab) is an anti-integrin biologic (alpha4beta7) made by Takeda Pharmaceuticals. It is commonly prescribed for: Ulcerative colitis (moderate-to-severe), Crohn's disease (moderate-to-severe).
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Takeda Pharmaceuticals U.S.A., Inc. · Entyvio
Patient pays: as little as $0 per dose (IV or Pen)
commercial insurance
Takeda Pharmaceuticals U.S.A., Inc. · Entyvio
uninsured · underinsured
Common questions